ICTAMMOLO ® is a drug based on ammonium sulfoittiolato
THERAPEUTIC GROUP: Anti-acne preparations for topical use
IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects
Indications ICTAMMOLO ® Ammonium sulfoittiolato
ICTAMMOLO ® is indicated in the treatment of inflammatory lesions of the skin such as abscesses, boils and ulcerations.
Mechanism of action ICTAMMOLO ® Ammonium sulfoittiolato
The sulfoittiolato ammonium, active ingredient of ICTAMMOLO ®, is a natural ointment obtained from the fusion of ammonia and metabolites of sulfuric acid characterized by the brownish color due to the high percentage of thiophene.
It is precisely the characteristic chemical composition that evidently determines its biological functions, being able to exert an anti-inflammatory, antimicrobial, keratolytic and sebostatic action, obviously due to the presence of sulfur, classically used in dermatology.
All the aforementioned activities therefore make it possible to adequately control the inflammatory lesions present also during acne, improving the clinical course and normalizing the skin appearance through the optimization of the processes of keratinization and sebum production, such as to reduce the risk of bacterial proliferation .
Furthermore, topical use significantly reduces the risk of clinically relevant adverse reactions.
Studies carried out and clinical efficacy
ICTAMMOLO IN DERMATOLOGY
Int J Dermatol. 2010 Jul; 49 (7): 757-60. doi: 10.1111 / j.1365-4632.2010.04551.x.
Work that demonstrates how strokeamine is used extensively in the treatment of psoriasis, dermatitis, seborrheic dermatitis, ulcers and boils, thus representing a good ally in a dermatological clinic.
ANTIBACTERIAL SPECTRUM OF THE ICTMOLOL
Clin Otolaryngol Allied Sci. 1995 Jun; 20 (3): 201-3.
Work demonstrating the efficacy of stroke as an anti-inflammatory and antibacterial potential effective against numerous Gram-positive and Gram-negative microorganisms.
THE ICTMOL IN THE TREATMENT OF THE OTITIS
Eur Arch Otorhinolaryngol. 2008 Aug; 265 (8): 881-5. Epub 2007 Oct 6.
Study demonstrating how Ictammol can be successfully used, in combination with other drugs, in the treatment of severe acute otitis externa, ensuring a clear improvement in the patient's clinical condition.
Method of use and dosage
ICTAMMOLO ®
Ointment for cutaneous use.
We recommend applying the appropriate amount of ointment directly on the lesion to be treated, taking care to gently massage the area.
It is recommended to use as needed, avoiding prolonged application of the drug.
Warnings ICTAMMOLO ® Ammonium sulfoittiolato
Before using ICTAMMOLO ® it would be advisable to consult your doctor with whom to assess the prescriptive appropriateness of the drug and the possible presence of contraindications.
Given the chemical nature of the product, it is generally advisable to avoid contact with eyes and mucous membranes, taking care therefore to cleanse your hands thoroughly after use and to avoid exposure to sunlight
It is also advisable to consider how the prolonged use of ICTAMMOLO ® could determine the appearance of local adverse reactions, fortunately clinically not relevant and transient.
Keep the medicine out of the reach of children.
PREGNANCY AND BREASTFEEDING
The use of ICTAMMOLO ® during pregnancy and in the subsequent period of breastfeeding should be evaluated and prescribed by your doctor.
Interactions
The patient receiving ICTAMMOLO ® should avoid the simultaneous use of other drugs topically.
Contraindications ICTAMMOLO ® Ammonium sulfoittiolato
The use of ICTAMMOLO ® is contraindicated in patients who are hypersensitive to the active ingredient or to one of its excipients.
Undesirable effects - Side effects
The use of ICTAMMOLO ®, above all when prolonged for a long time, could determine the appearance of local and transient adverse reactions such as burning, pain and irritation.
Note
ICTAMMOLO ® is a drug not subject to mandatory medical prescription.
